Lentiviral-mediated silencing of SOD1 through RNA interference retards disease onset and progression in a mouse model of ALS. - Archive ouverte HAL Access content directly
Journal Articles Nature Medicine Year : 2005

Lentiviral-mediated silencing of SOD1 through RNA interference retards disease onset and progression in a mouse model of ALS.

(1) , (1) , (1) , (1) , (2) , (1) , (3) , (1)
1
2
3

Abstract

Mutations in Cu/Zn superoxide dismutase (encoded by SOD1), one of the causes of familial amyotrophic lateral sclerosis (ALS), lead to progressive death of motoneurons through a gain-of-function mechanism. RNA interference (RNAi) mediated by viral vectors allows for long-term reduction in gene expression and represents an attractive therapeutic approach for genetic diseases characterized by acquired toxic properties. We report that in SOD1(G93A) transgenic mice, a model for familial ALS, intraspinal injection of a lentiviral vector that produces RNAi-mediated silencing of SOD1 substantially retards both the onset and the progression rate of the disease.
Embargoed file
Embargoed file
Ne sera jamais visible
Loading...

Dates and versions

inserm-00484530 , version 1 (18-05-2010)

Identifiers

Cite

Cédric Raoul, Toufik Abbas-Terki, Jean-Charles Bensadoun, Sandrine Guillot, Georg Haase, et al.. Lentiviral-mediated silencing of SOD1 through RNA interference retards disease onset and progression in a mouse model of ALS.. Nature Medicine, 2005, 11 (4), pp.423-8. ⟨10.1038/nm1207⟩. ⟨inserm-00484530⟩

Collections

INSERM UNIV-AMU
283 View
0 Download

Altmetric

Share

Gmail Facebook Twitter LinkedIn More